In our hospital, dose reduction or withdrawal of linezolid is considered in patients with an Hb level of ≤6.0 g/dL, but if this does not adequately treat the pancytopenia, blood transfusion therapy is an option. This evidence concerns the gene GSTM1 and Pancytopenia.